Barry Landau, MD
Neurological Surgery · Bellingham, WANPI 1053382671
Payments from drug & device makers
What this record shows
15 manufacturers reported payments, led by Globus Medical at 40.8% of the total. Reporting peaked in 2024 at $2,068 and has fallen 91.4% since, to $178 in 2025.
Across 109 payments — averaging $67.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$3K
- Medtronic$3K
- Abbott$583
- Si-bone, Inc.$269
- Surgalign Spine Technologies, Inc.$217
- Bioventus LLC$117
- plus $219 from 9 others
What the payments were for
- Travel & lodging$3,39646%
- Food & beverage$3,91154%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical(2 entities) | 13 | $2,984 |
| Medtronic(2 entities) | 60 | $2,917 |
| Abbott | 14 | $583 |
| Si-bone, Inc. | 5 | $269 |
| Surgalign Spine Technologies, Inc. | 4 | $217 |
| Bioventus LLC | 2 | $117 |
| Nevro Corp. | 2 | $50 |
| Boston Scientific | 1 | $31 |
| Stryker | 2 | $30 |
| Baxter Healthcare | 1 | $26 |
| Vertex | 1 | $24 |
| Sanara Medtech Inc. | 1 | $19 |
| Spineology Inc. | 1 | $16 |
| Biocomposites Inc | 1 | $15 |
| Augmedics Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,307 in reported general payments places this provider in the 70th percentile of 175 neurological surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 82 | $1,499 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 35 | $288 |
| Methylprednisolone | 49 | $270 |
| Cyclobenzaprine Hcl | 32 | $126 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 22 | $117 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Bellingham
- Ramana GorrepatiBellingham$60K
- Tung HaBellingham$11K
- Rod OskouianSeattle$2.4M
- Christoph HofstetterSeattle$768K
- David YamBrush Prairie$471K
- Stephen MonteithSeattle$151K
- Allan HellerSpokane$132K
- Jean-Christophe LevequeSeattle$120K
- Vijay YanamadalaSeattle$85K
- Hoan Vu TranSeattle$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.